Lasa Supergenerics Limited (BOM:540702)
7.20
+0.28 (4.05%)
At close: Aug 21, 2026
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 360.73 million as of August 21, 2026. Its market cap has decreased by -23.89% in one year.
Market Cap
360.73M
Enterprise Value
451.23M
Revenue
65.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.20
ChartMarket Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 360.73M, a decrease of -89.79%. That is a compound annual growth rate of -22.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 360.73M | -23.73% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.29B |
| Krebs Biochemicals & Industries | 1.17B |
| Tyche Industries | 1.06B |
| Vasundhara Rasayans | 490.87M |
| Crestchem | 377.55M |
| Alfavision Overseas (India) | 354.35M |
| Ishita Drugs and Industries | 227.26M |
| Venmax Drugs and Pharmaceuticals | 192.04M |